FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298001804> ?p ?o ?g. }

• W4298001804 abstract "Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease associated with a highly variable clinical presentation, including vasculitis, immunodeficiency, and hematologic manifestations, potentially progressing over time. The present study describes the long-term evolution of the immuno-hematological features and therapeutic challenge of two identical adult twin sisters affected by DADA2. The absence of plasmatic adenosine deaminase 2 (ADA2) activity in both twins suggested the diagnosis of DADA2, then confirmed by genetic analysis. Exon sequencing revealed a missense (p.Leu188Pro) mutation on the paternal ADA2 allele. While, whole genome sequencing identified an unreported deletion (IVS6_IVS7del*) on the maternal allele predicted to produce a transcript missing exon 7. The patients experienced the disease onset during childhood with early strokes (Patient 1 at two years, Patient 2 at eight years of age), subsequently followed by other shared DADA2-associated features, including neutropenia, hypogammaglobulinemia, reduced switched memory B cells, inverted CD4:CD8 ratio, increased naïve T cells, reduced follicular regulatory T cells, the almost complete absence of NK cells, T-large granular cell leukemia, and osteoporosis. Disease evolution differed: clinical manifestations presented several years earlier and were more pronounced in Patient 1 than in Patient 2. Due to G-CSF refractory life-threatening neutropenia, Patient 1 successfully underwent an urgent hematopoietic stem cell transplantation (HSCT) from a 9/10 matched unrelated donor. Patient 2 experienced a similar, although delayed, disease evolution and is currently on anti-TNF therapy and anti-infectious prophylaxis. The unique cases confirmed that heterozygous patients with null ADA2 activity deserve deep investigation for possible structural variants on a single allele. Moreover, this report emphasizes the importance of timely recognizing DADA2 at the onset to allow adequate follow-up and detection of disease progression. Finally, the therapeutic management in these identical twins raises significant concerns as they share a similar phenotype, with a delayed but almost predictable disease evolution in one of them, who could benefit from a prompt definitive treatment like elective allogeneic HSCT. Additional data are required to assess whether the absence of enzymatic activity at diagnosis is associated with hematological involvement and is also predictive of bone marrow dysfunction, encouraging early HSCT to improve functional outcomes." @default.
• W4298001804 created "2022-10-01" @default.
• W4298001804 creator A5001630246 @default.
• W4298001804 creator A5003588072 @default.
• W4298001804 creator A5011722048 @default.
• W4298001804 creator A5012542550 @default.
• W4298001804 creator A5016760892 @default.
• W4298001804 creator A5017292600 @default.
• W4298001804 creator A5026667594 @default.
• W4298001804 creator A5026770450 @default.
• W4298001804 creator A5028722083 @default.
• W4298001804 creator A5038019019 @default.
• W4298001804 creator A5038603934 @default.
• W4298001804 creator A5041838320 @default.
• W4298001804 creator A5042278832 @default.
• W4298001804 creator A5043831231 @default.
• W4298001804 creator A5045645624 @default.
• W4298001804 creator A5047233859 @default.
• W4298001804 creator A5052641999 @default.
• W4298001804 creator A5053235254 @default.
• W4298001804 creator A5056887177 @default.
• W4298001804 creator A5057871772 @default.
• W4298001804 creator A5060770003 @default.
• W4298001804 creator A5065659848 @default.
• W4298001804 creator A5066480716 @default.
• W4298001804 creator A5067354798 @default.
• W4298001804 creator A5068136804 @default.
• W4298001804 creator A5075416361 @default.
• W4298001804 creator A5075859652 @default.
• W4298001804 creator A5076765690 @default.
• W4298001804 creator A5078465262 @default.
• W4298001804 creator A5078844472 @default.
• W4298001804 creator A5079293591 @default.
• W4298001804 creator A5082083571 @default.
• W4298001804 creator A5084965410 @default.
• W4298001804 creator A5086388616 @default.
• W4298001804 creator A5087520444 @default.
• W4298001804 date "2022-09-29" @default.
• W4298001804 modified "2023-10-18" @default.
• W4298001804 title "Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency" @default.
• W4298001804 cites W1978297432 @default.
• W4298001804 cites W2037576540 @default.
• W4298001804 cites W2073123191 @default.
• W4298001804 cites W2102260696 @default.
• W4298001804 cites W2106578986 @default.
• W4298001804 cites W2119180969 @default.
• W4298001804 cites W2134555277 @default.
• W4298001804 cites W2136935019 @default.
• W4298001804 cites W2142014244 @default.
• W4298001804 cites W2146005104 @default.
• W4298001804 cites W2162224267 @default.
• W4298001804 cites W2170634666 @default.
• W4298001804 cites W2218796855 @default.
• W4298001804 cites W2338282253 @default.
• W4298001804 cites W2507602581 @default.
• W4298001804 cites W2582527364 @default.
• W4298001804 cites W2787719860 @default.
• W4298001804 cites W2805193212 @default.
• W4298001804 cites W2810265958 @default.
• W4298001804 cites W2943695445 @default.
• W4298001804 cites W2979936905 @default.
• W4298001804 cites W3000665008 @default.
• W4298001804 cites W3041314314 @default.
• W4298001804 cites W3042049568 @default.
• W4298001804 cites W3044949229 @default.
• W4298001804 cites W3080830525 @default.
• W4298001804 cites W3118839154 @default.
• W4298001804 cites W3129778528 @default.
• W4298001804 cites W3186357160 @default.
• W4298001804 cites W3195550532 @default.
• W4298001804 cites W3199157998 @default.
• W4298001804 cites W3206612596 @default.
• W4298001804 cites W4206742967 @default.
• W4298001804 cites W4284889047 @default.
• W4298001804 doi "https://doi.org/10.3389/fimmu.2022.910021" @default.
• W4298001804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36248833" @default.
• W4298001804 hasPublicationYear "2022" @default.
• W4298001804 type Work @default.
• W4298001804 citedByCount "1" @default.
• W4298001804 countsByYear W42980018042023 @default.
• W4298001804 crossrefType "journal-article" @default.
• W4298001804 hasAuthorship W4298001804A5001630246 @default.
• W4298001804 hasAuthorship W4298001804A5003588072 @default.
• W4298001804 hasAuthorship W4298001804A5011722048 @default.
• W4298001804 hasAuthorship W4298001804A5012542550 @default.
• W4298001804 hasAuthorship W4298001804A5016760892 @default.
• W4298001804 hasAuthorship W4298001804A5017292600 @default.
• W4298001804 hasAuthorship W4298001804A5026667594 @default.
• W4298001804 hasAuthorship W4298001804A5026770450 @default.
• W4298001804 hasAuthorship W4298001804A5028722083 @default.
• W4298001804 hasAuthorship W4298001804A5038019019 @default.
• W4298001804 hasAuthorship W4298001804A5038603934 @default.
• W4298001804 hasAuthorship W4298001804A5041838320 @default.
• W4298001804 hasAuthorship W4298001804A5042278832 @default.
• W4298001804 hasAuthorship W4298001804A5043831231 @default.
• W4298001804 hasAuthorship W4298001804A5045645624 @default.
• W4298001804 hasAuthorship W4298001804A5047233859 @default.
• W4298001804 hasAuthorship W4298001804A5052641999 @default.
• W4298001804 hasAuthorship W4298001804A5053235254 @default.
• W4298001804 hasAuthorship W4298001804A5056887177 @default.

• next